Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1991 Feb;8(2):204-9.
doi: 10.1023/a:1015892020468.

Influence of ultrasound on the percutaneous absorption of nicotinate esters

Affiliations
Clinical Trial

Influence of ultrasound on the percutaneous absorption of nicotinate esters

H A Benson et al. Pharm Res. 1991 Feb.

Abstract

The influence of ultrasound on the percutaneous absorption of three nicotinate esters was investigated in 10 healthy volunteers in a double-blind placebo controlled crossover clinical trial. Using a specially designed experimental protocol, the effect of continuous output ultrasound (at frequency 3.0 MHz and intensity 1.0 W/cm2 for 5 min) on the percutaneous absorption of methyl, ethyl, and hexyl nicotinates, from gel bases, was investigated. A placebo control, involving massage with each of the gels, without ultrasound for 5 min, was also incorporated. The pharmacodynamic parameter of vasodilation caused by the nicotinates was used to monitor the percutaneous absorption of the drugs. Laser Doppler velocimetry, a noninvasive optical technique, was used to measure vasodilation of the cutaneous vessels within the treatment site. Ultrasound treatment led to enhanced vasodilator response to the nicotinates, therefore indicating an enhancement of their percutaneous absorption. These agents may prove to be useful compounds in examination of the mechanism of action of phonophoresis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am J Physiol. 1977 Apr;232(4):H441-8 - PubMed
    1. J Pharm Sci. 1983 Sep;72(9):1077-9 - PubMed
    1. J Pharm Pharmacol. 1964 Dec;16:SUPPL:104-7T - PubMed
    1. Br J Clin Pharmacol. 1985 Oct;20(4):421-4 - PubMed
    1. J Invest Dermatol. 1984 May;82(5):515-7 - PubMed

Publication types

Substances